LINCOLN PHARMACEUTICALS
|
LINCOLN PHARMACEUTICALS Last 5 Year Income Statement History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
INCOME : | |||||
Gross Sales | ₹603 Cr | ₹535 Cr | ₹497 Cr | ₹439 Cr | ₹400 Cr |
Sales | ₹588 Cr | ₹522 Cr | ₹485 Cr | ₹424 Cr | ₹385 Cr |
Job Work/ Contract Receipts | ₹5.22 Cr | ₹7.45 Cr | ₹5.58 Cr | ₹4.70 Cr | ₹5.16 Cr |
Processing Charges / Service Income | - | - | ₹1.59 Cr | - | - |
Revenue from property development | - | - | - | - | - |
Other Operational Income | ₹9.33 Cr | ₹5.35 Cr | ₹3.93 Cr | ₹9.44 Cr | ₹9.65 Cr |
Less: Excise Duty | - | - | - | - | - |
Net Sales | ₹581 Cr | ₹510 Cr | ₹472 Cr | ₹424 Cr | ₹386 Cr |
EXPENDITURE : | |||||
Increase/Decrease in Stock | ₹-5.70 Cr | ₹-4.24 Cr | ₹-14 Cr | ₹3.99 Cr | ₹-8.41 Cr |
Raw Material Consumed | ₹210 Cr | ₹184 Cr | ₹183 Cr | ₹152 Cr | ₹147 Cr |
Opening Raw Materials | ₹21 Cr | ₹27 Cr | ₹18 Cr | ₹14 Cr | ₹12 Cr |
Purchases Raw Materials | ₹129 Cr | ₹109 Cr | ₹119 Cr | ₹85 Cr | ₹90 Cr |
Closing Raw Materials | ₹22 Cr | ₹21 Cr | ₹27 Cr | ₹18 Cr | ₹14 Cr |
Other Direct Purchases / Brought in cost | ₹83 Cr | ₹69 Cr | ₹74 Cr | ₹70 Cr | ₹58 Cr |
Other raw material cost | - | - | - | - | - |
Power & Fuel Cost | ₹11 Cr | ₹10 Cr | ₹8.33 Cr | ₹7.10 Cr | ₹8.19 Cr |
Electricity & Power | ₹11 Cr | ₹10 Cr | ₹8.33 Cr | ₹7.10 Cr | ₹8.19 Cr |
Oil, Fuel & Natural gas | - | - | - | - | - |
Coals etc | - | - | - | - | - |
Other power & fuel | - | - | - | - | - |
Employee Cost | ₹103 Cr | ₹93 Cr | ₹80 Cr | ₹63 Cr | ₹59 Cr |
Salaries, Wages & Bonus | ₹95 Cr | ₹88 Cr | ₹76 Cr | ₹59 Cr | ₹54 Cr |
Contributions to EPF & Pension Funds | ₹4.15 Cr | ₹3.43 Cr | ₹2.83 Cr | ₹2.68 Cr | ₹2.47 Cr |
Workmen and Staff Welfare Expenses | ₹3.56 Cr | ₹2.15 Cr | ₹1.31 Cr | ₹1.73 Cr | ₹1.79 Cr |
Other Employees Cost | - | - | - | - | - |
Other Manufacturing Expenses | ₹102 Cr | ₹86 Cr | ₹69 Cr | ₹62 Cr | ₹64 Cr |
Sub-contracted / Out sourced services | - | - | - | - | - |
Processing Charges | ₹16 Cr | ₹12 Cr | ₹10 Cr | ₹9.81 Cr | ₹11 Cr |
Repairs and Maintenance | ₹4.16 Cr | ₹4.35 Cr | ₹3.35 Cr | ₹3.68 Cr | ₹3.22 Cr |
Packing Material Consumed | ₹74 Cr | ₹62 Cr | ₹49 Cr | ₹42 Cr | ₹45 Cr |
Other Mfg Exp | ₹7.42 Cr | ₹7.84 Cr | ₹6.94 Cr | ₹6.18 Cr | ₹4.97 Cr |
General and Administration Expenses | ₹30 Cr | ₹31 Cr | ₹28 Cr | ₹23 Cr | ₹21 Cr |
Rent , Rates & Taxes | ₹2.78 Cr | ₹3.07 Cr | ₹4.24 Cr | ₹4.42 Cr | ₹1.61 Cr |
Insurance | ₹1.04 Cr | ₹0.63 Cr | ₹0.84 Cr | ₹0.62 Cr | ₹0.62 Cr |
Printing and stationery | ₹1.19 Cr | ₹1.30 Cr | ₹0.88 Cr | ₹0.90 Cr | ₹0.84 Cr |
Professional and legal fees | ₹16 Cr | ₹19 Cr | ₹17 Cr | ₹13 Cr | ₹11 Cr |
Traveling and conveyance | ₹7.30 Cr | ₹5.81 Cr | ₹2.88 Cr | ₹2.31 Cr | ₹6.02 Cr |
Other Administration | ₹1.84 Cr | ₹1.59 Cr | ₹1.86 Cr | ₹1.70 Cr | ₹1.58 Cr |
Selling and Distribution Expenses | ₹27 Cr | ₹19 Cr | ₹19 Cr | ₹25 Cr | ₹27 Cr |
Advertisement & Sales Promotion | ₹4.28 Cr | ₹4.81 Cr | ₹3.85 Cr | ₹12 Cr | ₹15 Cr |
Sales Commissions & Incentives | ₹14 Cr | ₹11 Cr | ₹12 Cr | ₹8.12 Cr | ₹9.68 Cr |
Freight and Forwarding | ₹3.29 Cr | ₹1.08 Cr | ₹2.61 Cr | ₹4.10 Cr | ₹2.38 Cr |
Handling and Clearing Charges | ₹0.08 Cr | ₹0.08 Cr | ₹0.06 Cr | ₹0.05 Cr | - |
Other Selling Expenses | ₹5.30 Cr | ₹2.17 Cr | ₹1.18 Cr | - | - |
Miscellaneous Expenses | ₹3.24 Cr | ₹2.28 Cr | ₹2.51 Cr | ₹1.64 Cr | ₹3.83 Cr |
Bad debts /advances written off | - | - | ₹0.70 Cr | - | ₹2.08 Cr |
Provision for doubtful debts | ₹0.65 Cr | - | - | ₹0.09 Cr | ₹0.04 Cr |
Losson disposal of fixed assets(net) | ₹0.28 Cr | - | ₹0.13 Cr | ₹0.05 Cr | ₹0.04 Cr |
Losson foreign exchange fluctuations | - | - | - | - | - |
Losson sale of non-trade current investments | - | - | - | - | - |
Other Miscellaneous Expenses | ₹2.31 Cr | ₹2.28 Cr | ₹1.68 Cr | ₹1.50 Cr | ₹1.68 Cr |
Less: Expenses Capitalised | - | - | - | - | - |
Total Expenditure | ₹481 Cr | ₹421 Cr | ₹377 Cr | ₹337 Cr | ₹321 Cr |
Operating Profit (Excl OI) | ₹100 Cr | ₹89 Cr | ₹95 Cr | ₹87 Cr | ₹66 Cr |
Other Income | ₹34 Cr | ₹22 Cr | ₹10.00 Cr | ₹5.66 Cr | ₹11 Cr |
Interest Received | ₹7.02 Cr | ₹6.17 Cr | ₹5.03 Cr | ₹2.24 Cr | ₹3.20 Cr |
Dividend Received | ₹0.00 Cr | - | - | ₹0.03 Cr | - |
Profit on sale of Fixed Assets | - | ₹0.08 Cr | - | - | - |
Profits on sale of Investments | ₹1.69 Cr | ₹0.75 Cr | ₹0.96 Cr | ₹0.07 Cr | ₹0.10 Cr |
Provision Written Back | - | ₹0.18 Cr | ₹0.17 Cr | - | - |
Foreign Exchange Gains | ₹4.61 Cr | ₹11 Cr | ₹1.11 Cr | ₹0.43 Cr | ₹7.74 Cr |
Others | ₹21 Cr | ₹4.38 Cr | ₹2.73 Cr | ₹2.91 Cr | ₹0.00 Cr |
Operating Profit | ₹134 Cr | ₹112 Cr | ₹105 Cr | ₹93 Cr | ₹77 Cr |
Interest | ₹1.47 Cr | ₹2.03 Cr | ₹1.45 Cr | ₹1.56 Cr | ₹2.02 Cr |
InterestonDebenture / Bonds | - | - | - | - | - |
Interest on Term Loan | ₹0.37 Cr | ₹0.54 Cr | ₹0.34 Cr | ₹0.29 Cr | - |
Intereston Fixed deposits | - | - | - | - | - |
Bank Charges etc | ₹0.52 Cr | ₹0.39 Cr | ₹0.53 Cr | ₹0.36 Cr | ₹0.52 Cr |
Other Interest | ₹0.57 Cr | ₹1.10 Cr | ₹0.58 Cr | ₹0.91 Cr | ₹1.50 Cr |
PBDT | ₹133 Cr | ₹110 Cr | ₹104 Cr | ₹91 Cr | ₹75 Cr |
Depreciation | ₹11 Cr | ₹9.17 Cr | ₹8.09 Cr | ₹7.56 Cr | ₹7.33 Cr |
Profit Before Taxation & Exceptional Items | ₹122 Cr | ₹100 Cr | ₹96 Cr | ₹84 Cr | ₹67 Cr |
Exceptional Income / Expenses | - | - | - | - | - |
Profit Before Tax | ₹122 Cr | ₹100 Cr | ₹96 Cr | ₹84 Cr | ₹67 Cr |
Provision for Tax | ₹29 Cr | ₹28 Cr | ₹27 Cr | ₹21 Cr | ₹16 Cr |
Current Income Tax | ₹25 Cr | ₹25 Cr | ₹24 Cr | ₹21 Cr | ₹16 Cr |
Deferred Tax | ₹3.50 Cr | ₹1.59 Cr | ₹0.72 Cr | ₹0.25 Cr | ₹0.04 Cr |
Other taxes | ₹0.24 Cr | ₹1.25 Cr | ₹1.37 Cr | ₹-0.07 Cr | ₹0.06 Cr |
Profit After Tax | ₹93 Cr | ₹73 Cr | ₹69 Cr | ₹62 Cr | ₹51 Cr |
Extra items | - | - | - | - | - |
Minority Interest | - | - | - | - | ₹-0.03 Cr |
Share of Associate | - | - | - | - | - |
Other Consolidated Items | - | - | - | - | - |
Consolidated Net Profit | ₹93 Cr | ₹73 Cr | ₹69 Cr | ₹62 Cr | ₹51 Cr |
Adjustments to PAT | - | - | - | - | - |
Profit Balance B/F | ₹418 Cr | ₹348 Cr | ₹282 Cr | ₹221 Cr | ₹176 Cr |
Appropriations | ₹511 Cr | ₹421 Cr | ₹352 Cr | ₹283 Cr | ₹228 Cr |
General Reserves | ₹0.50 Cr | ₹0.50 Cr | ₹0.50 Cr | ₹0.50 Cr | ₹0.50 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Corporate dividend tax | - | - | - | - | ₹0.62 Cr |
Other Appropriation | ₹3.01 Cr | ₹3.01 Cr | ₹3.00 Cr | - | ₹3.62 Cr |
Equity Dividend % | ₹18.00 | ₹15.00 | ₹15.00 | ₹15.00 | ₹15.00 |
Earnings Per Share | ₹46.58 | ₹36.40 | ₹34.63 | ₹31.08 | ₹25.72 |
Adjusted EPS | ₹46.58 | ₹36.40 | ₹34.63 | ₹31.08 | ₹25.72 |
Compare Income Statement of peers of LINCOLN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LINCOLN PHARMACEUTICALS | ₹1,569.8 Cr | -3.8% | 24.7% | 31.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹441,838.0 Cr | 1% | 4.6% | 47.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,107.0 Cr | 1% | -3.2% | 59.3% | Stock Analytics | |
CIPLA | ₹120,270.0 Cr | -1.1% | -0.3% | 20.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹113,077.0 Cr | 2.2% | 12.1% | 21.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,553.2 Cr | -2.7% | 0.8% | 43.8% | Stock Analytics |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LINCOLN PHARMACEUTICALS | -3.8% |
24.7% |
31.4% |
SENSEX | -2.1% |
-2% |
11.3% |
You may also like the below Video Courses